Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Patients with mental illness less likely to receive diet, exercise advice

  • Many transplant surgeons in U.S. suffer burnout, research suggests

  • Role of specialized protein affirmed in assuring normal cell development

  • People with disabilities experience unrecognized health disparities, new research shows

  • Strong connection between violence, mental illness in Guatemala during civil war lessens in postwar period

  • Why debunked autism treatment fads persist

  • Adults wtih disabilities screened for cancer less often

  • Can coffee reduce your risk of MS?

  • Optogenetic stimulation of the brain to control pain demonstrated in study

  • Emergency doctors and paramedics commonly misinterpret documents for end-of-life care choices, study finds

  •